Lv1
18 积分 2024-10-05 加入
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
3小时前
求助中
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
8天前
已完结
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study
16天前
已完结
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
5个月前
已完结
皖公网安备34019202002308
